創傷閉鎖市場規模、シェア、業界分析および予測　2024-2032年

Growth Factors of Wound Closure Market

The Wound Closure Market size was valued at USD 13.80 billion in 2023. The market is projected to grow from USD 23.51 billion in 2032, exhibiting a CAGR of 6.1% during the forecast period of 2024-2032.

創傷閉鎖市場規模は、2023年に138億米ドルと評価されました。市場は2032年の235億1000万米ドルから成長し、2024年から2032年の予測期間中に6.1%のCAGRを示すことが予測されています。

The COVID-19 pandemic negatively impacted the wound closure marketplace due to disruptions in healthcare services and supply chains. Elective surgical procedures, a huge motive force of wound closure products, were postponed or cancelled to prioritize COVID-19 cases, decreasing product demand. Lockdowns and manufacturing slowdowns led to delays in production and distribution. Additionally, reduced clinic visits and patient reluctance to are looking for non-emergency care similarly constrained marketplace boom. However, call for wound care in trauma and critical care settings endured. As healthcare structures get better and elective procedures resume, the market is expected to rebound, driven via innovation and increasing surgical methods globally.

A trend in the wound closure market is the development of superior adhesive technology that decorate restoration and minimize scarring. Innovations which include the Sylke Adhesive Wound Closure, identified in Allure’s Best of Beauty 2024 Breakthrough Awards, exemplify this development. Sylke utilizes clinical-grade silk fibroin to create a bendy, non-worrying dressing that actions with the skin, providing better person comfort and progressed surgical results. Such improvements address barriers of conventional wound dressings, supplying advanced patient reviews and outcomes.

A driving factor for the wound closure marketplace is the rising incidence of persistent wounds and surgical tactics globally. Conditions inclusive of diabetes and weight problems make a contribution to the growing incidence of ulcers and non-recovery wounds, necessitating advanced wound closure solutions. Additionally, the aging populace, more susceptible to accidents and surgical procedures, similarly boosts call for. Innovations in wound closure technologies, including absorbable sutures, adhesives, and minimally invasive gadgets, enhance healing effects and patient consolation. Increasing healthcare spending, specifically in rising economies, and the growing emphasis on enhancing postoperative care also make a contribution to the expansion of the wound closure market.

Comprehensive Analysis of Wound Closure Market

The Wound Closure Market growth is rising at an exponential rate due to its marketplace segmentation. This market expansion correctly affords a detailed local assessments thinking about the dominant supply and call for forces that effect the enterprise. These segmentations are methodically segregated by product type include sutures [absorbable and non-absorbable], hemostatic agents [active hemostats, passive hemostats, combination hemostats, and others], staplers [powered and manual], and others, by application include orthopedics, gynecology and obstetrics, general surgery, ophthalmology, cardiology, and others, by end-user include hospitals & ASCs, specialty clinics, and others.

The North America location lead the Wound Closure Market share percentage via benefitting a marketplace size of USD 5.20 billion due to increasing number of surgical procedures, substantial healthcare expenditure & infrastructure, growing adoption rate, among others.

The top players in the market play a crucial role in the industry assuring market growth and setting market standards. These players include, Boston Scientific Corporation, Frankenman International Ltd., CooperSurgical Inc., Intuitive Surgical, MANI,INC., Artivion, Inc.

March 2024: Intuitive Surgical secured 510(okay) clearance from the U.S. FDA for its da Vinci five, a next-technology multiport robotic machine. This advanced technology complements precision and flexibility in minimally invasive surgeries, reflecting Intuitive Surgical’s commitment to innovation and enhancing surgical consequences in healthcare through current robot solutions.

Segmentation Table

ATTRIBUTE        DETAILS

Study Period          2019-2032

Base Year               2023

Estimated Year      2024

Forecast Period     2024-2032

Historical Period  2019-2022

Growth Rate          CAGR of 6.1% from 2024-2032

Unit        Value (USD billion)

Segmentation        By Product Type

• Sutures
• Absorbable
• Non-Absorbable
• Hemostatic Agents
• Active Hemostats
• Passive Hemostats
• Combination Hemostats
• Others
• Staplers
• Powered
• Manual
• Others

By Application

• Orthopedics
• Gynecology and Obstetrics
• General Surgery
• Ophthalmology
• Cardiology
• Others

By End-User

• Hospitals & ASCs
• Specialty Clinics
• Others

By Region

North America (By Product Type, By Application, By End-User, and By Country)

• U.S.
• Canada

Europe (By Product Type, By Application, By End-User, and By Country/Sub-region)

• U.K.
• Germany
• France
• Italy
• Spain
• Scandinavia
• Rest of Europe

Asia Pacific (By Product Type, By Application, By End-User, and By Country/Sub-region)

• China
• Japan
• India
• Australia
• Southeast Asia
• Rest of Asia Pacific

Latin America (By Product Type, By Application, By End-User, and By Country/Sub-region)

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa (By Product Type, By Application, By End-User, and By Country/Sub-region)

• GCC
• South Africa
• Rest of the Middle East & Africa

Table of Contents

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Number of Key Procedures, by Key Countries/Region, 2023
4.2. New Product Launches – by Key Players
4.3. Technological Advancements in Wound Closure Market
4.4. Key Industry Developments – (Mergers, Acquisitions, Partnerships, etc.)
4.5. Impact of COVID-19 on the Wound Closure Market
5. Global Wound Closure Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Product Type
5.1.1. Sutures
5.1.1.1. Absorbable
5.1.1.2. Non-absorbable
5.1.2. Hemostatic Agents
5.1.2.1. Active Hemostats
5.1.2.2. Passive Hemostats
5.1.2.3. Combination Hemostats
5.1.2.4. Others
5.1.3. Staplers
5.1.3.1. Powered
5.1.3.2. Manual
5.1.4. Others
5.2. Market Analysis, Insights and Forecast – By Application
5.2.1. Orthopedics
5.2.2. Gynecology and Obstetrics
5.2.3. General Surgery
5.2.4. Ophthalmology
5.2.5. Cardiology
5.2.6. Others
5.3. Market Analysis, Insights and Forecast – By End User
5.3.1. Hospitals & ASCs
5.3.2. Specialty Clinics
5.3.3. Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
6. North America Wound Closure Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Product Type
6.1.1. Sutures
6.1.1.1. Absorbable
6.1.1.2. Non-absorbable
6.1.2. Hemostatic Agents
6.1.2.1. Active Hemostats
6.1.2.2. Passive Hemostats
6.1.2.3. Combination Hemostats
6.1.2.4. Others
6.1.3. Staplers
6.1.3.1. Powered
6.1.3.2. Manual
6.1.4. Others
6.2. Market Analysis, Insights and Forecast – By Application
6.2.1. Orthopedics
6.2.2. Gynecology and Obstetrics
6.2.3. General Surgery
6.2.4. Ophthalmology
6.2.5. Cardiology
6.2.6. Others
6.3. Market Analysis, Insights and Forecast – By End User
6.3.1. Hospitals & ASCs
6.3.2. Specialty Clinics
6.3.3. Others
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe Wound Closure Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Product Type
7.1.1. Sutures
7.1.1.1. Absorbable
7.1.1.2. Non-absorbable
7.1.2. Hemostatic Agents
7.1.2.1. Active Hemostats
7.1.2.2. Passive Hemostats
7.1.2.3. Combination Hemostats
7.1.2.4. Others
7.1.3. Staplers
7.1.3.1. Powered
7.1.3.2. Manual
7.1.4. Others
7.2. Market Analysis, Insights and Forecast – By Application
7.2.1. Orthopedics
7.2.2. Gynecology and Obstetrics
7.2.3. General Surgery
7.2.4. Ophthalmology
7.2.5. Cardiology
7.2.6. Others
7.3. Market Analysis, Insights and Forecast – By End User
7.3.1. Hospitals & ASCs
7.3.2. Specialty Clinics
7.3.3. Others
7.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Spain
7.4.5. Italy
7.4.6. Scandinavia
7.4.7. Rest of Europe
8. Asia Pacific Wound Closure Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Product Type
8.1.1. Sutures
8.1.1.1. Absorbable
8.1.1.2. Non-absorbable
8.1.2. Hemostatic Agents
8.1.2.1. Active Hemostats
8.1.2.2. Passive Hemostats
8.1.2.3. Combination Hemostats
8.1.2.4. Others
8.1.3. Staplers
8.1.3.1. Powered
8.1.3.2. Manual
8.1.4. Others
8.2. Market Analysis, Insights and Forecast – By Application
8.2.1. Orthopedics
8.2.2. Gynecology and Obstetrics
8.2.3. General Surgery
8.2.4. Ophthalmology
8.2.5. Cardiology
8.2.6. Others
8.3. Market Analysis, Insights and Forecast – By End User
8.3.1. Hospitals & ASCs
8.3.2. Specialty Clinics
8.3.3. Others
8.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. Southeast Asia
8.4.6. Rest of Asia Pacific
9. Latin America Wound Closure Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Product Type
9.1.1. Sutures
9.1.1.1. Absorbable
9.1.1.2. Non-absorbable
9.1.2. Hemostatic Agents
9.1.2.1. Active Hemostats
9.1.2.2. Passive Hemostats
9.1.2.3. Combination Hemostats
9.1.2.4. Others
9.1.3. Staplers
9.1.3.1. Powered
9.1.3.2. Manual
9.1.4. Others
9.2. Market Analysis, Insights and Forecast – By Application
9.2.1. Orthopedics
9.2.2. Gynecology and Obstetrics
9.2.3. General Surgery
9.2.4. Ophthalmology
9.2.5. Cardiology
9.2.6. Others
9.3. Market Analysis, Insights and Forecast – By End User
9.3.1. Hospitals & ASCs
9.3.2. Specialty Clinics
9.3.3. Others
9.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
10. Middle East & Africa Wound Closure Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Product Type
10.1.1. Sutures
10.1.1.1. Absorbable
10.1.1.2. Non-absorbable
10.1.2. Hemostatic Agents
10.1.2.1. Active Hemostats
10.1.2.2. Passive Hemostats
10.1.2.3. Combination Hemostats
10.1.2.4. Others
10.1.3. Staplers
10.1.3.1. Powered
10.1.3.2. Manual
10.1.4. Others
10.2. Market Analysis, Insights and Forecast – By Application
10.2.1. Orthopedics
10.2.2. Gynecology and Obstetrics
10.2.3. General Surgery
10.2.4. Ophthalmology
10.2.5. Cardiology
10.2.6. Others
10.3. Market Analysis, Insights and Forecast – By End User
10.3.1. Hospitals & ASCs
10.3.2. Specialty Clinics
10.3.3. Others
10.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
10.4.1. GCC
10.4.2. South Africa
10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
11.2.1. Johnson & Johnson Services, Inc.
11.2.1.1. Overview
11.2.1.2. Products
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Baxter
11.2.2.1. Overview
11.2.2.2. Products
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. Medtronic
11.2.3.1. Overview
11.2.3.2. Products
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. Artivion, Inc.
11.2.4.1. Overview
11.2.4.2. Products
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. Stryker
11.2.5.1. Overview
11.2.5.2. Products
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. 3M
11.2.6.1. Overview
11.2.6.2. Products
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. CP Medical (Riverpoint Medical)
11.2.7.1. Overview
11.2.7.2. Products
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. Boston Scientific Corporation
11.2.8.1. Overview
11.2.8.2. Products
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)
11.2.9. Smith+Nephew
11.2.9.1. Overview
11.2.9.2. Products
11.2.9.3. SWOT Analysis
11.2.9.4. Recent Developments
11.2.9.5. Strategies
11.2.9.6. Financials (Based on Availability)
11.2.10. B. Braun SE
11.2.10.1. Overview
11.2.10.2. Products
11.2.10.3. SWOT Analysis
11.2.10.4. Recent Developments
11.2.10.5. Strategies
11.2.10.6. Financials (Based on Availability)
11.2.11. MANI, INC.
11.2.11.1. Overview
11.2.11.2. Products
11.2.11.3. SWOT Analysis
11.2.11.4. Recent Developments
11.2.11.5. Strategies
11.2.11.6. Financials (Based on Availability)
11.2.12. CONMED Corporation
11.2.12.1. Overview
11.2.12.2. Products
11.2.12.3. SWOT Analysis
11.2.12.4. Recent Developments
11.2.12.5. Strategies
11.2.12.6. Financials (Based on Availability)
11.2.13. Genesis Medtech
11.2.13.1. Overview
11.2.13.2. Products
11.2.13.3. SWOT Analysis
11.2.13.4. Recent Developments
11.2.13.5. Strategies
11.2.13.6. Financials (Based on Availability)
11.2.14. CooperSurgical Inc.
11.2.14.1. Overview
11.2.14.2. Products
11.2.14.3. SWOT Analysis
11.2.14.4. Recent Developments
11.2.14.5. Strategies
11.2.14.6. Financials (Based on Availability)
11.2.15. Intuitive Surgical
11.2.15.1. Overview
11.2.15.2. Products
11.2.15.3. SWOT Analysis
11.2.15.4. Recent Developments
11.2.15.5. Strategies
11.2.15.6. Financials (Based on Availability)
11.2.16. Frankenman International Ltd.
11.2.16.1. Overview
11.2.16.2. Products
11.2.16.3. SWOT Analysis
11.2.16.4. Recent Developments
11.2.16.5. Strategies
11.2.16.6. Financials (Based on Availability)

Fortune Business Insights（フォーチュンビジネスインサイツ）は多様な産業を対象に市場調査を行い、市場動向、競争環境、将来予測などを盛り込んだ市場調査レポートを出版しています。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 提供ファイル：印刷不可PDF
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 提供ファイル：印刷不可PDF＋Excel
    • 同一企業内6名までレポートファイルのご共有が可能です。
  • エンタープライズライセンス
    • 提供ファイル：印刷可能PDF＋Excel
    • 同一企業内人数無制限でレポートファイルのご共有が可能です。
• 納品方法
  • Eメール
• 納期
  • レポートタイトルにより異なります。詳細はお気軽にお問い合わせください。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはFortune Business Insightsの日本の販売代理店として、Fortune Business Insightsのレポートを取り扱っております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にSEMABIZまでご連絡ください。

最新調査レポート

• 電気生理（EP）デバイス市場規模、シェア、業界分析および予測　2024-2032年
• 手術用照明市場規模、シェア、業界分析および予測　2024-2032年
• 眼科機器市場規模、シェア、業界分析および予測　2024-2032年
• ドローンソフトウェア市場規模、シェア、業界分析および予測　2024-2032年
• 冠動脈ステント市場規模、シェア、業界分析および予測　2025-2032年

Fortune Business Insights  出版レポート一覧